DMD and Duchenne muscular dystrophy: In recent years, AO-mediated exon-skipping has been a promising therapy for treating DMD by facilitating “Skipping” of specific dystrophin gene exon(s), thus to correct specific genetic mutations and restore production of dystrophin protein [4–13].